
Now there's an echinocandin antifungal to treat kids
Cancidas, previously approved for use in adults, can now be applied also to pediatric patients aged three months to 17 years.
Merck's Cancidas (caspofungin acetate), previously approved for use in adults, can now be applied also to pediatric patients aged three months to 17 years. The Whitehouse Station, N.J., firm claims that the approval makes
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.




















































































































































